|
COQ10B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.079400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.385000E-01 |
| Normal-vs-Stage2 |
2.881800E-01 |
| Normal-vs-Stage3 |
6.811400E-01 |
| Normal-vs-Stage4 |
1.642210E-01 |
| Stage1-vs-Stage2 |
1.391550E-01 |
| Stage1-vs-Stage3 |
3.768800E-01 |
| Stage1-vs-Stage4 |
3.594800E-01 |
| Stage2-vs-Stage3 |
4.772800E-01 |
| Stage2-vs-Stage4 |
9.342300E-02 |
| Stage3-vs-Stage4 |
1.724580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.840200E-01 |
| Normal-vs-AfricanAmerican |
4.942600E-01 |
| Normal-vs-Asian |
3.058000E-01 |
| Caucasian-vs-AfricanAmerican |
7.869500E-02 |
| Caucasian-vs-Asian |
6.839000E-01 |
| AfricanAmerican-vs-Asian |
3.604000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.165000E-01 |
| Normal-vs-Female |
4.037400E-01 |
| Male-vs-Female |
2.688200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.099200E-01 |
| Normal-vs-Extreme_Weight |
1.555030E-01 |
| Normal-vs-Obese |
9.200000E-01 |
| Normal-vs-Extreme_Obese |
3.002600E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.421200E-01 |
| Normal_Weight-vs-Obese |
3.629200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.722100E-02 |
| Extreme_Weight-vs-Obese |
2.109600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.540000E-02 |
| Obese-vs-Extreme_Obese |
1.869160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.779600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.334600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.264800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.211000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.307400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.015400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.294000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.085600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.041600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.729600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.215600E-01 |
| Normal-VS-Type2 PRCC |
4.767600E-01 |
| Normal-VS-KIRP CIMP |
4.398600E-01 |
| Normal-VS-Unclassified PRCC |
8.862200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.052420E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.018600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.519400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.060000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.981200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.315800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.866370E-01 |
| Normal-vs-N1 |
4.613600E-01 |
| Normal-vs-N2 |
8.840200E-01 |
| N0-vs-N1 |
7.092200E-01 |
| N0-vs-N2 |
7.171600E-01 |
| N1-vs-N2 |
8.362800E-01 |
|
|
